Infliximab reduces cardiac output in rheumatoid arthritis patients without heart failure Infliximabe reduz débito cardíaco em pacientes com artrite reumatoide sem insuficiência cardíaca

Infliximab reduces cardiac output in rheumatoid arthritis patients without heart failure Infliximabe reduz débito cardíaco em pacientes com artrite reumatoide sem insuficiência cardíaca

OBJECTIVE: Human anti-tumor necrosis factor (TNF-α) monoclonal antibody (infliximab) is used to treat autoimmune diseases such as rheumatoid arthritis (RA). Although the risk of worsening heart failure has been described in patients under chronic treatment, the acute cardiovascular effects...

Full description

Bibliographic Details
Main Authors: Rodrigo Cardoso Santos, Valéria Nasser Figueiredo, Luiz Cláudio Martins, Carolina de Haro Moraes, Thiago Quinaglia, Leandro Boer-Martins, Sílvia Elaine Ferreira-Melo, Michel Alexandre Yazbek, Manoel Bertolo, Heitor Moreno Junior
Format: Article
Language:English
Published: Associação Médica Brasileira 2012-12-01
Series:Revista da Associação Médica Brasileira
Subjects:
Infliximabe
inibidores de TNF-α
doenças autoimunes
artrite reumatoide
insuficiência cardíaca
Infliximab
TNF-α inhibitors
autoimmune diseases
rheumatoid arthritis
heart failure
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302012000600015

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302012000600015

Similar Items